This malignant transformation of thyrocytes is primarily initiated by the constitutive activation of the mitogen-activated protein kinase (MAPK) pathway, with additional recurring alterations such as loss of p53 and activation of TERT and the PI3K/AKT pathway promoting more aggressive and less differentiated thyroid cancer. Here, AKT1 is linked to thyroid gland carcinoma.